GlassScriptPhysician profile
David Michael Pilati
NPI 1184694499
$1,562.77
in general payments reported to CMS, 2019-2025
22 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $41.78 · 2021: $248 · 2022: $186 · 2023: $163 · 2024: $543 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $189.02 | 2024-2025 | Tisseel, Coseal |
| Standard Bariatrics, INC. | $145.91 | 2021 | |
| Abbvie INC. | $136.85 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $104.56 | 2019-2023 | Nascobal |
| Tela Bio, INC. | $98.80 | 2024 | Ovitex 2s |
| Novo Nordisk INC | $90.22 | 2022-2025 | Wegovy |
| Vivus LLC | $86.00 | 2021-2024 | Qsymia |
| Nestle Healthcare Nutrition INC. | $85.97 | 2021-2022 | |
| Ethicon US, LLC | $83.70 | 2019-2024 | Surgicel Nu-Knit, Stratafix, Vistaseal |
| Takeda Pharmaceuticals U.S.A., INC. | $75.40 | 2023-2024 | Gattex |
| Aimmune Therapeutics, INC. | $62.14 | 2024-2025 | Zenpep |
| Shire North American Group INC | $57.76 | 2019 | |
| Hologic Sales and Service, LLC | $56.36 | 2023-2024 | Coolseal Generator |
| Lilly USA, LLC | $54.11 | 2024-2025 | Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $52.63 | 2019-2023 | Dificid |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $52.20 | 2021-2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Heron Therapeutics, INC. | $35.55 | 2022-2023 | Aponvie |
| Davol INC. | $32.02 | 2019-2024 | Arista Ah Flexitip |
| Redhill Biopharma INC. | $23.11 | 2021 | |
| Coopersurgical, INC. | $15.20 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $13.77 | 2019 | |
| Echosens North America, INC. | $11.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Pilati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.